Status:
COMPLETED
Efficacy of Zoledronic Acid in Osteoporosis of Children With Multiple Disabilities
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Multiple Disability
Osteoporosis
Eligibility:
All Genders
Up to 18 years
Brief Summary
The main purpose of this study is the evaluation of the efficacy of zoledronic acid on bone density in children with osteoporosis caused by multiple disabilities. Secondary purposes are: 1. Descript...
Eligibility Criteria
Inclusion
- Non refusal of parents of participation of their child to the study
- Patients followed for multiple disabilities
- Osteoporosis: lumbar osteodensitometry z-score \<-2.5 SD associated or not to pathologic fracture
Exclusion
- Bone pathology due to other genetic reasons (rickets, osteogenesis imperfecta)
- Absence of multiple disabilities
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03301285
Start Date
January 1 2017
End Date
March 31 2017
Last Update
October 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital - CHRU de Nancy
Vandœuvre-lès-Nancy, France